Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “URINARY BLADDER”

4,189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,189 results

Not applicableStudy completedNCT05312138
What this trial is testing

Multiple Sclerosis and Overactive Bladder Treatment

Who this might be right for
Neurogenic Bladder Dysfunction
Istanbul Medipol University Hospital 16
Post-approval studies (Phase 4)Study completedNCT02536976
What this trial is testing

Mirabegron in Parkinson Disease and Impaired Cognition

Who this might be right for
Parkinson DiseaseOveractive BladderImpaired Cognition
HealthPartners Institute 7
Not applicableStudy completedNCT03063827
What this trial is testing

Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients

Who this might be right for
Neurogenic Bladder
Buddhist Tzu Chi General Hospital 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04640623
What this trial is testing

TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 220
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Not applicableLooking for participantsNCT05380661
What this trial is testing

Heart Rate Variability and Anxiety During Urinary Bladder Catheterization

Who this might be right for
Spinal Cord InjuriesUrinary Bladder, NeurogenicAnxiety State+2 more
University of British Columbia 20
Not applicableLooking for participantsNCT06289270
What this trial is testing

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

Who this might be right for
Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues
Theodor Bilharz Research Institute 38
Early research (Phase 1)Not Yet RecruitingNCT07119996
What this trial is testing

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 12
Not applicableUnknownNCT04144270
What this trial is testing

The Importance of Muscle Function in Patients With Disseminated Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasm
Rigshospitalet, Denmark 30
Not applicableStudy completedNCT06188078
What this trial is testing

The Effect of Bladder Stimulation Technique and Bathing Method on Urine Collection in Term Babies

Who this might be right for
Urine Specimen Collection
Maltepe University 102
Not applicableStudy completedNCT05042817
What this trial is testing

Effect of Intrathecal Morphine on Urinary Bladder Function and Recovery in Patients Having a Cesarean Delivery

Who this might be right for
Analgesia
University of Liege 56
Large-scale testing (Phase 3)Study completedNCT00444925
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Who this might be right for
Overactive Bladder
Pfizer 1,712
Not applicableStudy completedNCT04454970
What this trial is testing

Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction

Who this might be right for
TransgenderismCatheter Related Complication
University College, London 19
Not applicableStudy completedNCT03912558
What this trial is testing

Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients.

Who this might be right for
BPHBOO - Bladder Outflow Obstruction
Butterfly Medical Ltd. 92
Not applicableStudy completedNCT01180478
What this trial is testing

Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer

Who this might be right for
Bladder Cancer
Clinical Research Office of the Endourological Society 965
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Early research (Phase 1)Ended earlyNCT03960060
What this trial is testing

CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors

Who this might be right for
Solid TumorSoft Tissue SarcomaGastric Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 9
Post-approval studies (Phase 4)Ended earlyNCT01092624
What this trial is testing

Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse

Who this might be right for
Pelvic Organ Prolapse
Hartford Hospital 94
Large-scale testing (Phase 3)Study completedNCT03902080
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Overactive Bladder
Urovant Sciences GmbH 1,105
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 272
Load More Results